Skip to main content
. 2013 Jan 17;36(2):294–301. doi: 10.2337/dc12-0506

Table 2.

Crude incidence rate ratios by long-acting or intermediate-acting insulin for all malignancies and breast cancer

graphic file with name 294tbl2.jpg